Medtech startup Axio Biosolutions raises $6 Mn from TrueScale Capital, existing investors
Shortpedia
Content Team
Image Credit: Inc42
Axio Biosolutions, a Boston and Bengaluru-based medical device company has raised $6 Mn in Series B2 led by TrueScale Capital. Existing investors Omidyar Network India, University of California – Ratan Tata Fund, and Accel also participated in this funding round. With this deal, Sameer Nath, managing partner, TrueScale Capital, will join Axio’s board of directors.
